Vitamin D Enriched Meat Project (Acute Study)

Sponsor
University of Ulster (Other)
Overall Status
Completed
CT.gov ID
NCT04207294
Collaborator
Devenish Nutrition, Lagan House, 19 Clarendon Road, Belfast, BT1 3BG (Other), Agri-Food and Biosciences Institute (AFBI), 18a Newforge Lane, Belfast, BT9 5P (Other)
15
1
5
2.8
5.4

Study Details

Study Description

Brief Summary

The importance of achieving an adequate vitamin D status is widely recognised, with public health and research communities heightening their interest over recent years.

Whilst vitamin D can be synthesised following skin exposure to UV light, due to public health concerns regarding sun safety, and modern indoor lifestyles, it has become evident that endogenous synthesis may not be an effective means of maintaining an adequate vitamin D status across the year. Given the marked variation in seasonally-induced cutaneous synthesis, habitually low dietary vitamin D intakes of 2-4µg/day typically reported within nationally represented population surveys, and the generally low uptake of supplementation at the population level, it is warranted to identify alternative food-based strategies to yield greater adherence to the 10µg DRV, particularly during winter months where sunlight exposure is negligible. Commodity-based biofortification may provide an innovative and viable additional food-based approach to suboptimal vitamin D status, in combination with safe sun exposure, inclusion of natural and fortified dietary sources and/or supplementation.

Meat naturally contains vitamin D3 and 25(OH)D3, yet by manipulating feeding regimes and/ or housing environments, it is possible to improve the concentration of both metabolites in animal products. Eggs, beef and pork provide viable opportunities for the enhancement of vitamin D3 and 25(OH)D3 which contribute to an increase in total vitamin D activity (vitamin D3 + [25(OH)D3 x 5]), and therefore would be expected to positively impact vitamin D status. Albeit whilst much biofortification research has been established, less is known regarding its effectiveness at raising circulating serum 25(OH)D concentrations amongst apparently healthy adults, with the exception of some plant-based foods.

Therefore, an opportunity exists to understand the bioavailability of vitamin D-enriched pork and vitamin D-enriched chicken to increase 25(OH)D concentration.

Condition or Disease Intervention/Treatment Phase
  • Other: Pork arm
  • Other: Chicken arm
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Bioavailability of Vitamin D-enriched Pork and Chicken in Comparison to a Vitamin D Supplement in Healthy Adults: an Acute Study
Actual Study Start Date :
Jan 16, 2020
Actual Primary Completion Date :
Apr 10, 2020
Actual Study Completion Date :
Apr 10, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vitamin D-enriched pork

One portion of Vitamin D-enriched pork

Other: Pork arm
The effect of 1 portion of vitamin D-enriched pork on 25(OH)D concentration in comparison to a vitamin D supplement and control pork.

Placebo Comparator: Control pork

One portion of control pork

Other: Pork arm
The effect of 1 portion of vitamin D-enriched pork on 25(OH)D concentration in comparison to a vitamin D supplement and control pork.

Active Comparator: Vitamin D supplement

Equivocal dose of Vitamin D supplement

Other: Pork arm
The effect of 1 portion of vitamin D-enriched pork on 25(OH)D concentration in comparison to a vitamin D supplement and control pork.

Experimental: Vitamin D-enriched chicken

One portion of Vitamin D-enriched chicken

Other: Chicken arm
The effect of 1 portion of vitamin D-enriched chicken on 25(OH)D concentration in comparison to control chicken.

Placebo Comparator: Control chicken

One portion of control chicken

Other: Chicken arm
The effect of 1 portion of vitamin D-enriched chicken on 25(OH)D concentration in comparison to control chicken.

Outcome Measures

Primary Outcome Measures

  1. Change in vitamin D concentration [Change over 24 hours (baseline (0 hr), 1.5, 3, 6, 9, 24-hour)]

    Vitamin D3, vitamin D2, 25(OH)D3, 25(OH)D2) (nmol/L) in serum/plasma

Secondary Outcome Measures

  1. Calcium serum concentrations [Monitored over 24 hours (baseline (0 hr), 1.5, 3, 6, 9, 24-hour)]

    Adjusted calcium

  2. Parathyroid hormone (PTH) concentration [Change over 24 hours (baseline (0 hr), 1.5, 3, 6, 9, 24-hour)]

    Plasma levels

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • · Free-living, apparently healthy Caucasian adults

  • Aged 18-65 years at Recruitment

  • Body Mass Index (BMI) ≥18.5 and <25kg/m2

  • If consuming vitamin D supplements, willing to discontinue 4 weeks prior and for duration of study

  • Non-smokers

Exclusion Criteria:
  • · Non-Caucasian adults

  • Adults <18 or >65 years at recruitment

  • Taking vitamin D supplement and not willing to discontinue vitamin D supplementation for 4 weeks prior to and for duration of study

  • Current smokers

  • Pregnant/lactating females

  • Use of tanning facilities or winter vacation planned during the intervention period to a location expected to increase cutaneous synthesis

  • Severe medical illness

  • Medications which interfere with vitamin D metabolism e.g. steroid medications (e.g. prednisone), weight loss drug orlistat (e.g. Xenical and Alli), cholesterol-lowering drug cholestyramine (e.g. Questran, LoCholest and Prevalite), seizure drugs Phenobarbital and Dilantin, anti-tuberculosis, statins or thiazide diuretics

  • Intestinal malabsorption syndrome

  • Excessive alcohol use (>14 units/ week)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Human Intervention Studies Unit, Ulster University Coleraine Co.Londonderry United Kingdom BT52 1SA

Sponsors and Collaborators

  • University of Ulster
  • Devenish Nutrition, Lagan House, 19 Clarendon Road, Belfast, BT1 3BG
  • Agri-Food and Biosciences Institute (AFBI), 18a Newforge Lane, Belfast, BT9 5P

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Ulster
ClinicalTrials.gov Identifier:
NCT04207294
Other Study ID Numbers:
  • REC/19/0040
First Posted:
Dec 20, 2019
Last Update Posted:
Jun 14, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Ulster
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 14, 2021